Excelsior Medical Co., Ltd.

Total Valuation

Excelsior Medical Co., Ltd. carries a market capitalization of 13.47B, placing it among publicly traded companies globally. Its enterprise value stands at 15.14B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Excelsior Medical Co., Ltd. currently has 174.45M shares outstanding.

Valuation Ratios

Excelsior Medical Co., Ltd. trades at a trailing price-to-earnings ratio of 17.36. The price-to-sales ratio is 1.59, and the price-to-book ratio stands at 2.56.

Enterprise Valuation

On an enterprise value basis, Excelsior Medical Co., Ltd. trades at an EV/EBITDA multiple of 20.88 and an EV/FCF ratio of 53.84. The EV/Sales ratio of 1.72 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.88 provides insight into valuation relative to core operating earnings.

Financial Position

Excelsior Medical Co., Ltd. maintains a current ratio of 1.67, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.43, indicating elevated leverage, while an interest coverage ratio of 20.77 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Excelsior Medical Co., Ltd. posts a return on equity of 15.05 and a return on invested capital of 4.41.

Taxes

Over the trailing twelve months, Excelsior Medical Co., Ltd. has paid 216.30M in income taxes, reflecting an effective tax rate of 18.30.

Stock Price Statistics

Excelsior Medical Co., Ltd.'s stock has declined approximately -11.98917% over the past 52 weeks. The 50-day moving average sits at 73.68, while the 200-day moving average is 79.51.

Income Statement

Over the trailing twelve months, Excelsior Medical Co., Ltd. generated 8.79B in revenue and converted that into 805.86M in net income, yielding earnings per share of 5.53. EBITDA reached 725.41M, while operating income came in at 725.41M.

Balance Sheet

Excelsior Medical Co., Ltd. holds 3.53B in cash and equivalents against 2.16B in total debt, resulting in a net debt position of -1.15B. Total book value stands at 5.46B, with working capital of 4.17B providing operational flexibility.

Cash Flow

Excelsior Medical Co., Ltd. produced -1.36B in operating cash flow over the past twelve months. After subtracting -83.04M in capital expenditures, free cash flow totaled -1.45B - equivalent to -8.30 per share.

Margins

Excelsior Medical Co., Ltd. operates with a gross margin of 21.33, reflecting its pricing power and cost economics. The operating margin of 8.25 and net profit margin of 9.17 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Excelsior Medical Co., Ltd.'s most recent stock split took place on September 9, 2025 with a 20:21 split ratio.

Scores

Excelsior Medical Co., Ltd. posts an Altman Z-Score of 2.29, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.